Emcure Pharma IPO : Likely to come in H2FY11

by khalid on 15/04/2011 · 0 comments

Pune based Emcure Pharma Limited has informed the share market(BSE/NSE) that they have planning to enter capital markets with its initial public offer (IPO) of —- shares of Rs 10 each. The issue size would be around around Rs 650-700 crore and the IPO would hit the market in second half of the year. Emcure Pharmaceuticals researches, manufactures and markets formulations under its own brands in the domestic market and exports its own formulations to several countries is backed by the New York based Blackstone Group

The company, which researches, manufactures and markets formulations under its own brands in the domestic market and exports its own formulations to several countries is backed by the New York based Blackstone Group which invested USD 50 million in it in July 2006. This was Blackstone’s first investment in India since starting a private equity business in the South Asian nation, the company had said at the time.

The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

The Book Running Lead Manager to the Issue are Bank of America Corp., IDFC Capital Ltd and Morgan Stanley .

Established in 1983, Emcure has grown from a single manufacturing facility to a range of manufacturing facilities spread across Active Pharmaceutical Ingredients, formulations and biotechnology.

Stay tuned to BelltheBull Blog for more news on Emcure Pharma IPO !

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: